SCHEMBL4772156

SCHEMBL4772156

COc1ccc(F)cc1C(C)(C)C[C@@](O)(CC(=O)O)C(F)(F)F

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 19/20 0.69
NR3C2 P08235 10/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772164 1.00 NR3C1 (0.69) NR3C1NR3C2
SCHEMBL14587242 0.89 NR3C1 (0.64) NR3C1NR3C2
SCHEMBL5519954 0.87 NR3C1 (0.69) NR3C1NR3C2
SCHEMBL13632709 0.86 NR3C1 (0.52) NR3C1NR3C2
SCHEMBL14064838 0.86 NR3C1 (0.52) NR3C1NR3C2
SCHEMBL4223472 0.84 NR3C1 (0.65) NR3C1NR3C2
SCHEMBL1634952 0.84 NR3C1 (0.71) NR3C1NR3C2
SCHEMBL1775217 0.84 NR3C1 (0.71) NR3C1NR3C2
SCHEMBL15759110 0.84 NR3C1 (0.71) NR3C1NR3C2
SCHEMBL1775018 0.84 NR3C1 (0.67) NR3C1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1727818-B1 STEREOSELECTIVE SYNTHESIS OF CERTAIN TRIFLUOROMETHYL-SUBSTITUTED ALCOHOLS BOEHRINGER INGELHEIM PHARMA (US) 2008-07-23 EP disclosed
US-7179919-B2 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2007-02-20 US disclosed
US-20050209488-A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209488-A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols ADH1A, ADH1C, ADH5 NR3C1 132/4885NR3C2 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.